These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4217611)

  • 21. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.
    Wu H; Song Z; Hentzer M; Andersen JB; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2004 Jun; 53(6):1054-61. PubMed ID: 15117922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first phase of pseudomonadal pneumonia influenced by the administration of ampicillin + EDTA in vivo.
    Nezval J; Sedlácek J; Mráz J; Brázdová K
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):152-6. PubMed ID: 4987602
    [No Abstract]   [Full Text] [Related]  

  • 23. [A comparative study of the effects of aminoglycoside antibiotics].
    Hejzlar M; Kittnar E; Pellar T; Silarová J; Paroubek M; Hájková L; Sedmidubský V; Safránková M; Stastná L; Janatová E
    Cesk Epidemiol Mikrobiol Imunol; 1982 Nov; 31(6):375-82. PubMed ID: 6216968
    [No Abstract]   [Full Text] [Related]  

  • 24. Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium.
    Davis SD; Iannetta A; Wedgwood RJ
    J Infect Dis; 1971 Dec; 124(6):610-2. PubMed ID: 4331350
    [No Abstract]   [Full Text] [Related]  

  • 25. Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model.
    Zuravleff JJ; Chervenick P; Yu VL; Muder RR; Diven WF
    J Lab Clin Med; 1984 Jun; 103(6):878-85. PubMed ID: 6427375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
    Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
    Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined action of sulfamethoxazole, trimethoprim, and ethylenediaminetetraacetic acid on Pseudomonas aeruginosa.
    Rawal BD; Owen WR
    Appl Microbiol; 1971 Feb; 21(2):367-8. PubMed ID: 4994355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antibacterial effect of neomycin, quaternary ammonium compounds and combinations of these substances on Pseudomonas aeruginosa.
    Tăborsky I; Nezval J; Smékal E; Janisch R
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):359-67. PubMed ID: 4980473
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial therapy in experimental pseudomonas infection. II.
    McDaniel RC; Southern PM
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):375-84. PubMed ID: 4364246
    [No Abstract]   [Full Text] [Related]  

  • 31. Antimicrobial therapy in experimental pseudomonas infection.
    Thomas MZ; Southern PM
    Tex Rep Biol Med; 1974; 32(2):569-77. PubMed ID: 4372741
    [No Abstract]   [Full Text] [Related]  

  • 32. Chloroxylenol and EDTA kill P. aeruginosa.
    Worsely CR
    Med J Aust; 1982 Sep; 2(5):220. PubMed ID: 6813662
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pseudomonas pyocyanea infections in otorhinolaryngology].
    Nicoucar GR
    Pract Otorhinolaryngol (Basel); 1969; 31(6):359-64. PubMed ID: 4314671
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanisms of resistance in Pseudomonas aeruginosa].
    Cercenado Mansilla E; García Garrote F
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():10-6. PubMed ID: 9844472
    [No Abstract]   [Full Text] [Related]  

  • 35. [The significance of ethylenediaminotetraacetic acid (EDTA) in microbiological research].
    Nezval J; Ritzerfeld W
    Arch Hyg Bakteriol; 1969 Oct; 153(5):438-46. PubMed ID: 4989121
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study of the resistance of hospital and nonhospital strains of Pseudomonas aeruginosa to antibacterial preparations].
    Krasil'nikov AP; Adarchenko AA; Krylov IA
    Antibiotiki; 1982 Jan; 27(1):25-9. PubMed ID: 6800301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chelation in experimental Pseudomonas keratitis.
    Wilson LA
    Br J Ophthalmol; 1970 Sep; 54(9):587-93. PubMed ID: 4318751
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental preventive properties of a complex of Pseudomonas aeruginosa and Clostridium tetani anatoxins].
    Podgornaia LG; Dziuban NF; Kalinichenko NF; Isaeva SIa
    Mikrobiol Zh (1978); 1987; 49(5):55-8. PubMed ID: 3150503
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa].
    Torres A; Vega J; Aguirre M; Alés JM
    Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy of Pseudomonas aeruginosa infection in trauma and orthopedic patients].
    Mel'nikova VM; Arutcheva AA
    Antibiotiki; 1983 Sep; 28(9):689-93. PubMed ID: 6416157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.